Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neucardin in Chronic Systolic Heart Failure
NCT04468529Phase 3Completed
- Sponsor
- Zensun
- Start
- Dec 2020
- Primary completion
- Apr 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of neucardin in chronic systolic heart failure (HFrEF), sponsored by Zensun. Started Dec 2020; status: completed.
02
Drugs
neucardin
03
Conditions
chronic systolic heart failure (HFrEF)
Beyond the preview
Go deeper on NCT04468529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04468529.